These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33882931)

  • 1. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
    Wang P; Fang L
    World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.
    Yinon Y; Beiner ME; Gotlieb WH; Korach Y; Perri T; Ben-Baruch G
    Fertil Steril; 2007 Aug; 88(2):479-84. PubMed ID: 17408624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
    Li N; Ming X; Li Z
    Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological and Reproductive Outcomes of Cystectomy Compared with Unilateral Salpingo-Oophorectomy as Fertility-Sparing Surgery in Patients with Apparent Early Stage Pure Immature Ovarian Teratomas.
    Wang D; Zhu S; Jia C; Cao D; Yang J; Xiang Y
    Ann Surg Oncol; 2021 Oct; 28(11):6684-6693. PubMed ID: 33772392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral salpingo-oophorectomy as fertility-sparing surgery for borderline ovarian tumors.
    Tsai HW; Ko CC; Yeh CC; Chen YJ; Twu NF; Chao KC; Yen MS
    J Chin Med Assoc; 2011 Jun; 74(6):250-4. PubMed ID: 21621167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
    Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
    Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.
    Wang L; Zhong Q; Tang Q; Wang H
    Arch Gynecol Obstet; 2022 Oct; 306(4):1177-1183. PubMed ID: 35396974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery.
    Delle Marchette M; Ceppi L; Andreano A; Bonazzi CM; Buda A; Grassi T; Giuliani D; Sina F; Lamanna M; Bianchi T; Lissoni AA; Landoni F; Valsecchi MG; Fruscio R
    Eur J Cancer; 2019 Apr; 111():61-68. PubMed ID: 30826658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma).
    Koskas M; Uzan C; Gouy S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
    Hum Reprod; 2011 Apr; 26(4):808-14. PubMed ID: 21262776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study.
    Poncelet C; Fauvet R; Boccara J; Daraï E
    Ann Surg Oncol; 2006 Apr; 13(4):565-71. PubMed ID: 16491337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of hysterectomy on oncological outcomes in patients with borderline ovarian tumors: A systematic review and meta-analysis.
    Raimondo D; Raffone A; Zakhari A; Maletta M; Vizzielli G; Restaino S; Travaglino A; Krishnamurthy S; Mabrouk M; Casadio P; Mollo A; Scambia G; Seracchioli R
    Gynecol Oncol; 2022 Apr; 165(1):184-191. PubMed ID: 35090745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative surgery for borderline ovarian tumors--emphasis on fertility preservation. A review.
    Koutlaki N; Dimitraki M; Zervoudis S; Sofiadou V; Grapsas X; Psillaki A; Nikas I; Galazios G; Liberis V; Voiculescu S; Burcoş T
    Chirurgia (Bucur); 2011; 106(6):715-22. PubMed ID: 22308907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
    Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
    Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours.
    Song T; Hun Choi C; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
    Hum Reprod; 2011 Aug; 26(8):2008-14. PubMed ID: 21511712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.